We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TALO.WS
7676
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$4K ﹤0.01%
2,477
-3,160
-56% -$3.12K
DIVC
7677
DELISTED
C-Tracks Exchange Traded Notes Miller/Howard Strategic Dividend Reinvestor Due September 16, 2024
DIVC
$4K ﹤0.01%
110
TRQ
7678
DELISTED
Turquoise Hill Resources Ltd
TRQ
$4K ﹤0.01%
495
-3,827
-89% -$19.7K
GRAF.U
7679
DELISTED
Graf Industrial Corp. Units, each consisting of One share of Common Stock and One redeemable Warrant
GRAF.U
$4K ﹤0.01%
+347
New +$3.65K
PSV
7680
DELISTED
Hermitage Offshore Services Ltd.
PSV
$4K ﹤0.01%
3,216
+2,642
+460% +$2.88K
AFH
7681
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$4K ﹤0.01%
8,862
-21,128
-70% -$10.7K
SMRT
7682
DELISTED
Stein Mart Inc
SMRT
$4K ﹤0.01%
6,512
+3,825
+142% +$2.92K
QES
7683
DELISTED
Quintana Energy Services Inc.
QES
$4K ﹤0.01%
1,252
+859
+219% +$1.87K
OTTW
7684
DELISTED
Ottawa Bancorp, Inc. Common Stock
OTTW
$4K ﹤0.01%
298
TIBRW
7685
DELISTED
Tiberius Acquisition Corporation Warrant
TIBRW
$4K ﹤0.01%
3,850
+2,750
+250% +$3.14K
VLRX
7686
DELISTED
VALERITAS HOLDINGS INC
VLRX
$4K ﹤0.01%
+6,599
New +$9.12K
BLPH
7687
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4K ﹤0.01%
+834
New +$5.3K
SPHS
7688
DELISTED
Sophiris Bio, Inc.
SPHS
$4K ﹤0.01%
11,426
+5,914
+107% +$2.69K
FXCH
7689
DELISTED
Invesco CurrencyShares Chinese Renminbi Trust
FXCH
$4K ﹤0.01%
52
-158
-75% -$10.9K
AEHL icon
7690
Antelope Enterprise Holdings
AEHL
$8.03M
$3K ﹤0.01%
+1
New +$5.43K
AMTD
7691
AMTD IDEA Group
AMTD
$74.3M
$3K ﹤0.01%
64
-300
-82% -$15K
AREC icon
7692
American Resources Corp
AREC
$217M
$3K ﹤0.01%
5,187
+283
+6% +$184
ARKR icon
7693
Ark Restaurants
ARKR
$20.2M
$3K ﹤0.01%
150
ARMP icon
7694
Armata Pharmaceuticals
ARMP
$172M
$3K ﹤0.01%
780
+208
+36% +$837
AUSF icon
7695
Global X Adaptive US Factor ETF
AUSF
$912M
$3K ﹤0.01%
+100
New +$2.55K
AYTU icon
7696
AYTU BioPharma
AYTU
$23.7M
$3K ﹤0.01%
+16
New +$3.07K
BIBL icon
7697
Inspire 100 ETF
BIBL
$495M
$3K ﹤0.01%
+112
New +$3.25K
CLDX icon
7698
Celldex Therapeutics
CLDX
$3.07B
$3K ﹤0.01%
1,515
-3,232
-68% -$7.5K
CMDY icon
7699
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$549M
$3K ﹤0.01%
67
-3,215
-98% -$144K
CNCR
7700
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$3K ﹤0.01%
+139
New +$2.94K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.